Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -
Sponsor: Seoul National University Hospital
A PHASE4 clinical study on In-stent Restenosis Lesion, this trial is ongoing. The trial is conducted by Seoul National University Hospital and has accumulated 6 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2021 — May 2023 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Seoul National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .